KeifeRx’s robust development pipeline leverages mechanisms of action inherent to Kinase Inhibitors which thus far have been underexplored. Our technologies are designed to treat neurodegenerative diseases and an array of inflammatory diseases where there are significant unmet clinical needs and limited therapeutic options, resulting in painful, life-diminishing, and discomforting consequences for patients.
